Abstract
Objective: The aim of this study was to determine whether intrauterine lavage (IUL) samples from patients with high-grade serous carcinoma (HGSC) of the ovary, fallopian tube, or peritoneum harbor detectable genetic mutations and whether they reflect their matched tumor somatic mutation profiles. Our goal was to optimize mutation detection methods and shed light on novel diagnostic and screening techniques for ovarian cancer.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
